India, June 24 -- Treace Medical Concepts, Inc. (TMCI) enters the second half of 2026 with several near-term milestones, led by the anticipated full commercialization of its HyperPlate XM dynamic compression locking implant system and management's reiterated expectations for a return to stronger growth in the second half of the year.
Treace, a medical technology company focused on bunion and midfoot deformity correction, recently completed the first surgical case using its HyperPlate XM system, a next-generation titanium implant designed to deliver dynamic compression and enhanced stability across larger midfoot and hindfoot fusion procedures.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Servic...